Dhruwa N Rai
CIK 1672632 · SVP, CIDO · last filed 2022-07-08
Dhruwa N Rai is a SVP, CIDO who has filed 10 SEC Form 4 insider transactions across 2 companies since 2017. The most recent filing, for KWR, was dated Jul 8, 2022. Across all open-market trades the lifetime net is +$598.5K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $37.1K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
AMRHW price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
PRINCETON, NJ 08540
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| KWR | SVP, CIDO | 238 | $156.07 | $37.1K | $0 | 1 | 2022-07-08 |
| Enveric Biosciences, Inc. (AMRHW) Delisted | Director | 1,159,792 | — | — | $598.5K | 4 | 2018-02-12 |
Recent Filings
10 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2022-07-08 | KWR | Grant (A) | +238 | $0 | EDGAR |
| 2018-02-12 | Enveric Biosciences, Inc. (AMRHW) Delisted | Mixed | +174,921 | $0 | EDGAR |
| 2018-01-03 | Enveric Biosciences, Inc. (AMRHW) Delisted | Exer (M) | +7,680 | $0 | EDGAR |
| 2017-12-26 | Enveric Biosciences, Inc. (AMRHW) Delisted | Exer (M) | +333,333 | $0 | EDGAR |
| 2017-11-21 | Enveric Biosciences, Inc. (AMRHW) Delisted | Buy (P) | +145,450 | $598.5K | EDGAR |
| 2017-05-23 | — | Exer (M) | +3,329 | $0 | |
| 2017-05-03 | — | Mixed | +3,329 | -$11.8K | |
| 2017-04-14 | — | Grant (A) | — | $0 | |
| 2017-03-06 | — | Buy (P) | — | $0 | |
| 2016-05-10 | — | Grant (A) | — | $0 |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.